February 27, 2018 / 1:52 PM / 7 months ago

BRIEF-Actinium Pharmaceuticals Announces Activation Of 16th Clinical Trial Site

Feb 27 (Reuters) - Actinium Pharmaceuticals Inc:

* ACTINIUM PHARMACEUTICALS ANNOUNCES ACTIVATION OF SIXTEENTH CLINICAL TRIAL SITE IN THE PIVOTAL PHASE 3 SIERRA TRIAL FOR IOMAB-B

* ACTINIUM PHARMACEUTICALS INC - ACTIVATED SIXTEEN CLINICAL TRIAL SITES IN PHASE 3 SIERRA TRIAL​

* ACTINIUM PHARMACEUTICALS INC - ‍EXPECTS TO PROVIDE UPDATES ON IOMAB-B SIERRA TRIAL IN LINE WITH PREVIOUSLY STATED OBJECTIVES FOR 2018 AND 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below